Wellbutrin is the brand name for bupropion, a medication classified as a norepinephrine-dopamine reuptake inhibitor (NDRI). Unlike the more commonly prescribed SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors), Wellbutrin works primarily by increasing levels of norepinephrine and dopamine in the brain rather than serotonin.
The FDA has approved bupropion for three specific uses:
Notably absent from that list is anxiety. Wellbutrin is not FDA-approved for the treatment of any anxiety disorder. This distinction matters because it shapes how psychiatrists approach prescribing bupropion for anxiety — and why understanding the nuances of its use is essential before starting or switching to this medication.
Bupropion is available in three formulations: immediate-release (IR), sustained-release (SR), and extended-release (XL). The XL formulation, taken once daily, is the most commonly prescribed version today due to its convenience and steadier blood levels throughout the day.
This is where the clinical picture becomes nuanced. The short answer: possibly, in certain situations — but it depends heavily on the type of anxiety, whether depression is also present, and how an individual responds to the medication.
Because bupropion acts on norepinephrine and dopamine rather than serotonin, its effects on anxiety differ fundamentally from SSRIs like sertraline (Zoloft) or escitalopram (Lexapro), which are first-line treatments for most anxiety disorders. Some patients with depression and co-occurring anxiety experience improvement in both conditions when taking Wellbutrin. Others — particularly those with primary anxiety disorders without depression — may find that bupropion provides little benefit or even worsens their anxiety symptoms.
The key distinction psychiatrists consider: Is anxiety the primary diagnosis, or is it secondary to depression? When anxiety is a symptom of an underlying depressive disorder, treating the depression with bupropion can indirectly reduce anxiety. When anxiety is the standalone primary condition — such as generalized anxiety disorder (GAD), panic disorder, or social anxiety disorder — SSRIs and SNRIs remain the evidence-based first choice.
Several clinical studies have demonstrated that bupropion can reduce anxiety symptoms in patients whose primary diagnosis is major depression with comorbid anxiety. A pooled analysis published in the Journal of Clinical Psychiatry examined data from multiple randomized controlled trials and found that bupropion XL significantly reduced anxiety symptoms — as measured by the Hamilton Anxiety Rating Scale (HAM-A) — compared to placebo in patients with MDD and high baseline anxiety. The effect size was comparable to SSRIs in this specific population.
A 2008 study in Annals of Clinical Psychiatry compared bupropion XL with escitalopram in patients with major depression and comorbid anxiety. Both medications produced clinically meaningful reductions in anxiety scores, with no statistically significant difference between the two groups at eight weeks. This finding challenged the assumption that bupropion is inherently inferior to SSRIs for anxiety when depression is the primary driver.
Research examining bupropion in patients with co-occurring GAD and depression has produced mixed but noteworthy results. A study in Human Psychopharmacology found that bupropion SR was effective for both depressive and anxious symptoms in patients diagnosed with both conditions, though the anxiolytic effect appeared secondary to depression improvement rather than a direct anti-anxiety mechanism.
For isolated GAD without depression, the evidence is substantially weaker. No large-scale randomized controlled trial has established bupropion as an effective monotherapy for GAD alone, which is a primary reason it lacks FDA approval for anxiety disorders.
Head-to-head comparisons between bupropion and SSRIs for anxiety treatment consistently show that SSRIs are more reliable for primary anxiety disorders. A meta-analysis published in CNS Spectrums (2018) concluded that while bupropion demonstrates anxiolytic properties in depressed populations, it does not match the breadth of evidence supporting SSRIs and SNRIs for stand-alone anxiety disorders including GAD, panic disorder, social anxiety disorder, and OCD.
However, the same body of research highlights an important caveat: for patients who cannot tolerate SSRIs — whether due to sexual side effects, weight gain, emotional blunting, or gastrointestinal issues — bupropion represents a viable alternative that may address both depressive and anxious symptoms with a different side-effect profile.
Despite lacking FDA approval for anxiety, bupropion is prescribed off-label for anxiety-related concerns in several clinical scenarios. Off-label prescribing is legal, common in psychiatry, and often supported by clinical evidence even when formal FDA indications have not been pursued by the manufacturer. Here are the most common situations where a psychiatrist might choose Wellbutrin for a patient with anxiety:
SSRIs are effective for anxiety, but they are not without drawbacks. Some adults experience significant fatigue, emotional numbness, gastrointestinal distress, or other side effects that make long-term SSRI use difficult. Bupropion, with its activating dopaminergic profile, may serve as an alternative that treats co-occurring depressive and anxious symptoms without the serotonergic side-effect burden.
Depression and anxiety frequently overlap — studies suggest that approximately 60% of adults with major depression also meet criteria for at least one anxiety disorder. When a psychiatrist determines that depression is the primary condition driving secondary anxiety, bupropion may effectively address both. This is particularly relevant when choosing among depression treatment options and weighing side-effect profiles.
Sexual dysfunction — including decreased libido, delayed orgasm, and erectile difficulty — is one of the most common reasons adults discontinue SSRIs. Bupropion is one of the few antidepressants with a neutral or even positive effect on sexual function. For patients who need pharmacological treatment for depression with anxiety but find SSRI-related sexual side effects unacceptable, Wellbutrin offers a meaningful advantage.
Many SSRIs and SNRIs are associated with weight gain over time. Bupropion is weight-neutral or mildly weight-reducing, making it an attractive option for adults who have experienced medication-related weight gain or for whom weight management is a treatment priority. This practical consideration often tips the prescribing decision when efficacy for anxiety is expected to be comparable.
One of the most important things to understand about Wellbutrin and anxiety is that the relationship runs in both directions. While some patients experience anxiety relief, others report that bupropion increases their anxiety — particularly during the first few weeks of treatment.
Bupropion's mechanism of action — boosting norepinephrine and dopamine — produces a mildly stimulating effect in some patients. Unlike SSRIs, which tend to have a calming or even sedating quality, Wellbutrin can feel activating. For some adults, this translates to increased energy and motivation. For others, it manifests as jitteriness, restlessness, or heightened anxiety. This wellbutrin anxiety side effect is one of the most frequently reported concerns during the early treatment phase.
Clinical experience shows that anxiety symptoms triggered by bupropion frequently diminish after the first two to four weeks of treatment as the body adjusts to the medication. Psychiatrists typically counsel patients to expect a possible initial increase in anxiety and to allow adequate time before concluding that the medication is not working. Starting at a lower dose and titrating slowly can minimize this adjustment period.
The likelihood of experiencing anxiety as a side effect appears to increase with higher doses. Patients taking 450 mg daily (the maximum recommended dose) report anxiety more frequently than those on 150 mg or 300 mg. This is one reason psychiatrists often start with the lowest effective dose and increase gradually based on response and tolerability.
If you notice that your anxiety significantly worsens after starting or increasing your Wellbutrin dose, contact your prescribing psychiatrist. Dose adjustment, switching formulations (from IR to XL, for example), or adding an adjunctive medication may resolve the issue. Never stop bupropion abruptly without medical guidance.
Understanding how Wellbutrin compares to SSRIs can help frame the conversation with your psychiatrist. Here is a side-by-side comparison of key factors:
| Factor | Wellbutrin (Bupropion) | SSRIs (e.g., Sertraline, Escitalopram) |
|---|---|---|
| FDA-approved for anxiety | No | Yes (varies by specific SSRI and disorder) |
| Mechanism | NDRI (norepinephrine + dopamine) | Serotonin reuptake inhibition |
| Best evidence for anxiety | Comorbid depression + anxiety | Primary anxiety disorders (GAD, panic, social anxiety, OCD) |
| Sexual side effects | Minimal to none | Common (30-70% of patients) |
| Weight effects | Neutral or mild weight loss | Weight gain over time (common) |
| Energy/activation | Mildly stimulating | Neutral to mildly sedating |
| Risk of worsening anxiety | Higher (especially early in treatment) | Lower (may also occur briefly) |
| Seizure risk | Dose-dependent; higher than SSRIs | Very low |
If your psychiatrist prescribes bupropion to address both depression and anxiety, the formulation and dosing strategy matter. Here is how the three versions compare:
Wellbutrin IR (Immediate-Release): Taken two to three times daily. This is the original formulation. The multiple daily doses can lead to peak-and-trough fluctuations in blood levels, which some patients experience as intermittent anxiety or agitation. It is less commonly prescribed today for this reason.
Wellbutrin SR (Sustained-Release): Taken twice daily. Provides more stable blood levels than IR, reducing the peak-related side effects. This formulation is sometimes preferred when cost is a consideration, as generic bupropion SR is widely available.
Wellbutrin XL (Extended-Release): Taken once daily. Provides the most consistent blood levels throughout the day and is generally associated with the lowest incidence of anxiety as a side effect. Wellbutrin XL for anxiety-related uses is the most frequently chosen formulation when off-label anxiety management is part of the treatment goal.
Typical dosing progression:
Your psychiatrist will individualize dosing based on your symptoms, medical history, and response. Patients with anxiety concerns are often kept at 150 mg longer before increasing to 300 mg to monitor for anxiety worsening.
Beyond the anxiety-related effects discussed above, bupropion carries a side-effect profile that differs from SSRIs in important ways:
Seizure risk: Bupropion lowers the seizure threshold in a dose-dependent manner. The risk is approximately 0.1% at doses up to 300 mg/day and increases to 0.4% at 450 mg/day. Risk factors that further increase seizure likelihood include a history of seizures, eating disorders (anorexia or bulimia), heavy alcohol use, abrupt discontinuation of alcohol or benzodiazepines, and use of other medications that lower the seizure threshold. Bupropion is contraindicated in patients with seizure disorders or active eating disorders.
Black box warning: Like all antidepressants, bupropion carries an FDA black box warning regarding the potential for increased suicidal thoughts in young adults (ages 18-24) during early treatment. This risk requires close monitoring by your psychiatrist, particularly in the first few weeks after starting or changing doses.
If you are currently taking Wellbutrin and wondering whether it is working, recognizing the timeline and milestones of treatment response can help you and your psychiatrist evaluate next steps.
If you are considering Wellbutrin for anxiety — or if your current medication is not adequately controlling your symptoms — bring these questions to your next appointment:
At Elevate Psychiatry, our board-certified psychiatrists specialize in evidence-based medication management for adults with depression, anxiety, and co-occurring conditions. We understand that choosing the right medication involves more than matching a drug to a diagnosis — it requires a thorough evaluation of your symptoms, medical history, treatment goals, and lifestyle.
Whether you are exploring Wellbutrin as an alternative to SSRIs, managing medication side effects, or seeking a comprehensive treatment plan that may include therapy and lifestyle modifications, our team provides personalized care tailored to your needs.
We offer appointments at our offices in Coral Gables/Coconut Grove and Doral, as well as virtual psychiatry appointments across Florida.
Ready to discuss whether Wellbutrin is the right choice for your anxiety and depression? Call us at 305-908-1115 or book an appointment online.
Does Wellbutrin help with anxiety?
Wellbutrin may help reduce anxiety in adults whose anxiety is secondary to depression. However, it is not FDA-approved for anxiety disorders and is not considered a first-line treatment for primary anxiety conditions such as GAD, panic disorder, or social anxiety disorder. The clinical evidence is strongest when depression and anxiety co-occur.
Can Wellbutrin make anxiety worse?
Yes. Because bupropion has a mildly stimulating mechanism of action, some patients experience increased anxiety, restlessness, or agitation — particularly during the first two to four weeks of treatment or at higher doses. This side effect often improves as the body adjusts, but should be reported to your psychiatrist.
Is Wellbutrin or Zoloft better for anxiety?
For primary anxiety disorders, Zoloft (sertraline) has stronger clinical evidence and FDA approval. Wellbutrin may be preferred when anxiety co-occurs with depression and the patient cannot tolerate SSRI side effects such as sexual dysfunction or weight gain. The best choice depends on your specific diagnosis and medical history.
How long does it take for Wellbutrin to work for anxiety?
If Wellbutrin is going to help with anxiety symptoms, initial improvement is typically noticeable within two to four weeks, with full effects at six to eight weeks. Some patients experience a temporary increase in anxiety during the first week or two before improvement begins.
What is the best Wellbutrin dose for anxiety?
There is no specific FDA-recommended dose for anxiety because Wellbutrin is not approved for this use. Psychiatrists typically start at 150 mg XL daily and may increase to 300 mg XL after one to two weeks. The extended-release (XL) formulation is generally preferred for anxiety-prone patients because it provides the most stable blood levels.
Can you take Wellbutrin with an SSRI for anxiety?
Yes, combining bupropion with an SSRI is a common strategy in psychiatry. Bupropion can offset SSRI-related sexual side effects and weight gain while the SSRI addresses anxiety. However, this combination requires careful medical supervision and is not appropriate for everyone.
Who should not take Wellbutrin?
Bupropion is contraindicated in people with seizure disorders, active eating disorders (anorexia or bulimia), those abruptly discontinuing alcohol or sedatives, and those currently taking or recently stopped an MAOI. Your psychiatrist will evaluate your full medical history before prescribing.
Medical Disclaimer: This article is for
Want to understand the science? Learn how Wellbutrin works at the neurochemical level.
informational purposes only and does not constitute medical advice. Wellbutrin (bupropion) is a prescription medication that should only be taken under the supervision of a licensed healthcare provider. Do not start, stop, or change the dose of any medication without consulting your psychiatrist or physician. Individual responses to medication vary, and this article does not replace a personalized clinical evaluation. If you are experiencing a mental health crisis, call 988 (Suicide & Crisis Lifeline) or go to your nearest emergency room.Related reading: For a detailed week-by-week breakdown, see our guide on how long Wellbutrin takes to work and what to expect during the first few weeks.
For a focused look at the evidence, see our guide on bupropion for anxiety disorders.
Considering Wellbutrin or other psychiatric medications? Elevate Psychiatry offers virtual medication management across Florida, including online psychiatry in Winter Park and virtual psychiatric care in Bradenton.
Considering long-term Wellbutrin use? Learn about the side effects to watch for over time: Wellbutrin Long-Term Side Effects: What to Know Before Starting.
If you have bipolar disorder, antidepressants like Wellbutrin may trigger mania. Understand what causes mania and common triggers for manic episodes.
If you have bipolar disorder, antidepressants like Wellbutrin may trigger mania. Understand what causes mania and common triggers for manic episodes.
Related Reading: Citalopram (Celexa)
Considering an SSRI instead? Learn how Prozac works for anxiety and what to expect from fluoxetine treatment.
